With AP | Without AP | Total | p-value | |
---|---|---|---|---|
Cases, n (%) | 132 (38.4) | 212 (61.6) | 344 | |
Women, n (%) | 92 (69.7) | 153 (72.2) | 245 (71.2) | 0.62 |
Mean age ± SD | 80.9 ± 8.6 | 82.9 ± 7.2 | 82.1 ± 7.8 | 0.02 |
ADL score (4-24) mean ± SD | 11.9 ± 5.2 | 12.2 ± 5.4 | 12.1 ± 5.3 | 0.63 |
Cognitive score (0-27) mean ± SD | 10.6 ± 7.4 | 10.0 ± 7.2 | 10.2 ± 7.3 | 0.47 |
Antidepressant (N06A) use, n (%) | 73 (55.3) | 107 (50.5) | 180 (52.3) | 0.38 |
Anxiolytics, hypnotics and sedatives (N05B&C) use, n (%) | 72 (54.5) | 84 (39.6) | 156 (45.3) | 0.007 |
Anxiolytics (N05B) use, n (%) | 28 (21.2) | 18 (8.5) | 46 (13.4) | 0.001 |
Hypnotics and sedatives (N05C) use, n (%) | 63 (47.7) | 76 (35.8) | 139 (40.4) | 0.029 |
Anti-dementia drugs (N06D) use, n (%) | 26 (19.7) | 45 (21.2) | 71 (20.6) | 0.733 |